TECH OUTLOOK 6NOVEMBER - 2021EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharmaceutical industry is currently undergoing a massive revamp. Even though the sector had initially been slow in the adoption of technology, it is now contributing to technological advancements in a big way. These technological advancements, in turn, is bringing forth more investments toward innovation. The use of the latest technological tools, in that regard, is paving the pathway to better patient care as well as more meaningful intra- and inter-organisational collaboration.For instance, the use of artificial intelligence (AI) based analytics in drug discovery and development processes are facilitating more personalised medicine and drug delivery methods. This tech-driven approach is also reducing the probability of adverse drug reaction (ADR) and increasing the chances of easy regulatory approval. Besides, AI and ML can also help in patient identification for clinical trials. AI is also simplifying the identification and analysis of eligibility criteria of patients to make the trial cohort identification process faster and more effective. And the use of automation is allowing pharma companies to tackle these tasks with a fewer number of people.When all things are considered, there is no doubt that analytics in the pharma sector is on the fast track of evolution. Standing at the cusp of emerging technologies, there is a wide range of pharma analytics solution providers that are offering the latest technologies best suited for the next generation of pharma needs. In this edition of Pharma Tech Outlook Europe, we bring you the story of some of the best-of-breed pharma analytics solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best pharma analytics partners according to your requirements.Let us know your thoughts!A Tech-Driven Approach to Pharmaceutical DevelopmentsTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 25 - 2021, Vol 07 - Issue 12 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >